Objective:Explore the effectiveness of implantable intravenous infusion port application in malignant tumor patients.Method:The study included 90 patients with malignant tumors,all of whom were admitted to Xiamen Traditional Chinese Medicine Hospital from May 2022 to May 2023.The patients were divided into two groups based on different catheterization methods:45 venous catheterization groups(using central venous catheterization through peripheral veins)and 45 infusion port groups(using implantable venous infusion ports).Compare the application status of two groups,including puncture catheterization and operation,record the occurrence of catheter related complications in patients,and compare the quality of life of patients after catheter use through follow-up.Result:The comparison of various observation indicators between the infusion port group and the venous catheter group showed no significant difference in the success rate of one-time catheterization between the two groups(P＞0.05).The infusion port group had significantly higher rates of accidental extubation and complications(P＜0.05),longer catheterization operation time(P＜0.05),longer catheter retention time(P＜0.05),and significantly higher quality of life scores after catheter retention(P＜0.05).Conclusion:The use of implantable intravenous infusion ports in the treatment of malignant tumor patients can effectively prolong the retention time,which is beneficial for reducing accidental extubation and complications.Patients with indwelling catheters have less limited life and activity,and have a higher quality of life,which is worth promoting.
Malignant tumorsChemotherapyImplantable intravenous infusion portQuality of Life
万方数据
维普
